Figure 2
Figure 2. Kaplan-Meier survival analysis for (A) the entire patient cohort (n = 75, black line) and patients treated with curative (n = 39, gray line) and noncurative (n = 36, dashed line) intent. (B) Kaplan-Meier curves comparing OS in patients who underwent allo-SCT (n=17, gray line) and patients treated with induction chemotherapy who achieved either CR/CRi or cMPN (n=13, black line). (C) Landmark Kaplan-Meier analysis comparing patients who underwent allo-SCT (n=17, gray line) and patients who were treated with induction chemotherapy and survived at least 184 d post-LT, the median time to HCT (n=12, black line). (D) Kaplan-Meier analysis comparing patients treated with induction chemotherapy who achieved either CR/CRi or cMPN but were not transplanted (n=13, black line) and patients who were treated with nonintensive chemotherapy (n=15, gray line). For all curves, statistical analysis was performed using the Mantel-Cox log-rank test.

Kaplan-Meier survival analysis for (A) the entire patient cohort (n = 75, black line) and patients treated with curative (n = 39, gray line) and noncurative (n = 36, dashed line) intent. (B) Kaplan-Meier curves comparing OS in patients who underwent allo-SCT (n=17, gray line) and patients treated with induction chemotherapy who achieved either CR/CRi or cMPN (n=13, black line). (C) Landmark Kaplan-Meier analysis comparing patients who underwent allo-SCT (n=17, gray line) and patients who were treated with induction chemotherapy and survived at least 184 d post-LT, the median time to HCT (n=12, black line). (D) Kaplan-Meier analysis comparing patients treated with induction chemotherapy who achieved either CR/CRi or cMPN but were not transplanted (n=13, black line) and patients who were treated with nonintensive chemotherapy (n=15, gray line). For all curves, statistical analysis was performed using the Mantel-Cox log-rank test.

Close Modal

or Create an Account

Close Modal
Close Modal